High-Dose Chemotherapy with Stem Cell Rescue in Desmoplastic Small Round Cell Tumor: A Single-Institution Experience and Review of the Literature.
Kayleen A BaileyMichael RothDaniel WeiserJonathan D GillPublished in: Sarcoma (2018)
Given the poor prognosis in DSRCT, this study supports further prospective research into the possible benefit of consolidation of autologous SCT in patients with DSRCT who are in remission, with the alternative inference that these patients in remission may fare well without SCT. Our retrospective review of the literature does not support SCT for patients who are not in remission.
Keyphrases
- poor prognosis
- stem cells
- high dose
- end stage renal disease
- disease activity
- long non coding rna
- single cell
- cell therapy
- ulcerative colitis
- ejection fraction
- newly diagnosed
- chronic kidney disease
- low dose
- peritoneal dialysis
- prognostic factors
- rheumatoid arthritis
- systemic lupus erythematosus
- squamous cell carcinoma
- cross sectional
- mesenchymal stem cells
- platelet rich plasma
- rectal cancer
- patient reported